Jinpei Zhou
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents 8
- Organic Chemistry top 5%
- Synthesis and biological activity 5
- Molecular Biology top 10%
- Protein Degradation and Inhibitors 20
- Ubiquitin and proteasome pathways 13
- Histone Deacetylase Inhibitors Research 7
- Biochemistry top 10%
- Hematology top 10%
- Multiple Myeloma Research and Treatments 16
-
- Diabetes Treatment and Management 9
-
- Peptidase Inhibition and Analysis 8
Jinpei Zhou
90 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 99
- Toxicology 79
- Organic Chemistry 474
- Molecular Biology 745
- Biochemistry 72
- Hematology 111
Countries citing papers authored by Jinpei Zhou
This map shows the geographic impact of Jinpei Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinpei Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinpei Zhou more than expected).
Fields of papers citing papers by Jinpei Zhou
This network shows the impact of papers produced by Jinpei Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinpei Zhou. The network helps show where Jinpei Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jinpei Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 21 | |
| 3 | 2022 | 33 | |
| 4 | 2021 | 7 | |
| 5 | 2020 | 7 | |
| 6 | 2020 | 3 | |
| 7 | 2020 | 21 | |
| 8 | 2019 | 11 | |
| 9 | 2019 | 10 | |
| 10 | 2019 | 9 | |
| 11 | 2019 | 9 | |
| 12 | 2018 | 21 | |
| 13 | 2017 | 14 | |
| 14 | 2012 | 47 | |
| 15 | 2011 | 34 | |
| 16 | 2011 | 8 | |
| 17 | 2011 | 9 | |
| 18 | 2010 | 11 | |
| 19 | 2008 | 21 | |
| 20 | Selective reduction of andrographolide | 2003 | 1 |
About Jinpei Zhou
Jinpei Zhou is a scholar working on Toxicology, Hematology and Biological Psychiatry, having authored 90 papers that have together received 1.4k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (20 papers), Multiple Myeloma Research and Treatments (16 papers), Ubiquitin and proteasome pathways (13 papers), Diabetes Treatment and Management (9 papers), Bioactive Compounds and Antitumor Agents (8 papers), Peptidase Inhibition and Analysis (8 papers), Histone Deacetylase Inhibitors Research (7 papers) and Synthesis and biological activity (5 papers). The work is most often cited by research in Toxicology (79 citations), Organic Chemistry (474 citations) and Molecular Biology (745 citations). Jinpei Zhou has collaborated with scholars based in China, Austria and Germany. Frequent co-authors include Huibin Zhang, Xinrui Yuan, Hong Bu, Chao‐Yie Yang, Wenlong Huang, Lingyun Yang, Leilei Zhao, Qing Li, Xiaojun Yang and Yifei Yang. Their work appears in journals such as Diabetes, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.